[Expression of pituitary tumor-transforming gene in patients with multiple myeloma]
Zhao Wang1, Quan-Yi Lu, Ping Chen
1Department of Hematology, Zhongshan Hospital, Xiamen University, Xiamen 361012, China.
Abstract:
To explore the expression of pituitary tumor-transforming gene (PTTG) in elderly patients with multiple myeloma (MM) and its relationship with MM, the expressions of PTTG mRNA were detected in bone marrow mononuclear cells (BMMNC) from 33 patients with MM and 10 normal controls by using reverse transcriptase-polymerase chain reaction (RT-PCR). The results showed that the expression of PTTG mRNA in MM patients (0.3415 +/- 0.2172) was significantly higher than that in normal controls (0.0590 +/- 0.0233) (P < 0.05). It is concluded that the overexpression of oncogene PTTG may be related to genesis and progression of MM. It provided a new ideas to study the pathogenesis and gene therapy for MM patients.
Insights
Pituitary tumor-transforming gene (PTTG) was overexpressed in elderly multiple myeloma (MM) patients. This finding suggests PTTG may play a role in the development and progression of MM.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Multiple myeloma (MM) is a cancer of plasma cells.
- The role of specific genes in MM pathogenesis requires further investigation, particularly in elderly populations.
Purpose:
- To investigate the expression levels of pituitary tumor-transforming gene (PTTG) in elderly patients diagnosed with multiple myeloma (MM).
- To determine the correlation between PTTG expression and the presence or progression of MM.
Summary:
- PTTG mRNA expression was quantified in bone marrow mononuclear cells (BMMNC) from 33 MM patients and 10 healthy controls using reverse transcriptase-polymerase chain reaction (RT-PCR).
- Results indicated significantly higher PTTG mRNA expression in MM patients (0.3415 +/- 0.2172) compared to normal controls (0.0590 +/- 0.0233) (P < 0.05).
- The oncogene PTTG's overexpression is implicated in the genesis and progression of multiple myeloma.
Impact:
- This research suggests that PTTG may be a contributing factor to the development and advancement of multiple myeloma.
- The findings offer novel insights for exploring the pathogenesis of MM and developing potential gene-targeted therapies.


